(Q35105968)

6 August 2017

title

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility (English)

1 reference

6 August 2017

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

23 December 2023

1 reference

genetic predisposition to disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692171

23 December 2023

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

American Society of Clinical Oncology

23 December 2023

author

1

object named as

American Society of Clinical Oncology

1 reference

6 August 2017

language of work or name

English

0 references

publication date

11 April 2003

1 reference

full work available at URL

6 August 2017

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.03.189

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

Journal of Clinical Oncology

23 December 2023

published in

1 reference

6 August 2017

volume

21

1 reference

6 August 2017

issue

12

1 reference

6 August 2017

page(s)

2397-2406

1 reference

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

6 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

Resource document for curriculum development in cancer genetics education. American Society of Clinical Oncology

23 December 2023

2

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

Ethical issues with genetic testing in pediatrics

23 December 2023

3

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

Genetic testing for children and adolescents. Who decides?

23 December 2023

4

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1.

23 December 2023

7

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

The use and interpretation of commercial APC gene testing for familial adenomatous polyposis

23 December 2023

8

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

Laws restricting health insurers' use of genetic information: impact on genetic discrimination

23 December 2023

10

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

23 December 2023

11

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

Advocating for genetics at the local level: the Medicare Part B Carrier Advisory Committee

23 December 2023

12

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

Gene-Expression Profiles in Hereditary Breast Cancer

23 December 2023

13

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

Informed consent for population-based research involving genetics

23 December 2023

16

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

Informed consent for genetic research on stored tissue samples

23 December 2023

17

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.03.189

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference